Ana Godoy-Ortíz

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial

Ana Oaknin, Laurence Gladieff, Jerónimo Martínez-García et al. · The Lancet · 2023 · 175 citations

Oncology, Cervical Cancer, Metronomic Therapy +6

Significant Decrease in Annual Cancer Diagnoses in Spain during the COVID-19 Pandemic: A Real-Data Study

Sofía Ruiz-Medina, S Justo Gil, Begoña Jiménez et al. · Cancers · 2021 · 36 citations · Full text

Bevacizumab for recurrent, persistent or advanced cervical cancer: reproducibility of GOG 240 study results in “real world” patients

Ana Godoy-Ortíz, Y. Plata, Julia Alcaide et al. · Clinical & Translational Oncology · 2017 · 31 citations

Advanced Cervical Cancer, Study Results, Cervical Cancer Management +11

Comparative study of droplet-digital PCR and absolute Q digital PCR for ctDNA detection in early-stage breast cancer patients

Victoria Sánchez-Martín, Esperanza López-López, Diego Reguero-Paredes et al. · Clinica Chimica Acta · 2023 · 26 citations · Full text

Machine learning and natural language processing (NLP) approach to predict early progression to first-line treatment in real-world hormone receptor-positive (HR+)/HER2-negative advanced breast cancer patients

Nuria Ribelles, José M. Jerez, Pablo Rodríguez-Brazzarola et al. · European Journal of Cancer · 2020 · 23 citations · Full text

Natural Language Processing, Breast Oncology, Oncology +8